Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Chall...
May 02 2016 - 9:51AM
Business Wire
Fresenius Renal Therapies, a division of Fresenius Medical Care
North America (FMCNA), the leading provider of products and
services for the chronic kidney disease patient, announced today
the introduction of its latest technological enhancement in the
Crit-Line® technology product line, the CLiC™ device.
The CLiC device non-invasively measures hematocrit, oxygen
saturation and percent change in intravascular blood volume during
a patient’s hemodialysis (HD) treatment. As an integrated feature
in the 2008T hemodialysis machine, the organization’s flagship HD
delivery system, the healthcare professional has immediate,
real-time access to a patient’s hematocrit, percent change in blood
volume and oxygen saturation data, as well as essential dialysis
treatment information needed to make informed intradialytic
adjustments.
Fluid overload is a common and serious problem that can lead to
severe complications in dialysis patients and is a major cause of
reported hospitalizations in this population. Bringing dialysis
patients’ fluid overload under control has been a central focus of
clinicians and policy makers for many years.
“We have been looking forward to the release of CLiC
technology,” said Mark Costanzo, President, Renal Therapies Group.
“Fluid overload in dialysis patients is an important issue that
needs to be addressed. I’m proud to support the introduction of a
technological breakthrough that will allow nephrologists to have
access to important data and make informed decisions that will
directly impact the health and well-being of this chronically-ill
population. Fresenius Renal Therapies is dedicated to working with
nephrologists and dialysis clinicians in a continued effort to
improve patient outcomes and overall quality of life.”
The CLiC device is designed to allow the health care
professional to remove the maximum amount of fluid from the
hemodialysis patient while preventing the common symptoms of
dialysis such as nausea, cramping and vomiting, thus providing a
more effective treatment.
“The CLiC device represents a significant step forward in the
evolution of volume management,” said Frank Maddux, MD, Chief
Medical Officer of FMCNA. “By assisting clinical staff in managing
hemodialysis patients’ complex fluid and intravascular volume
conditions, the CLiC will be a valuable tool for clinicians.
Moreover, with the integration of the CLiC device into the 2008T
machine, clinical staff can more quickly recognize a patient's risk
for low blood pressure during hemodialysis resulting from certain
ultrafiltration and intravascular blood volume characteristics.
Once the CLiC device alerts staff, they can pause ultrafiltration
until the clinicians can assess the situation of their patient.
This industry-leading device is a significant step forward in
improving patients’ quality of life.”
For customers utilizing other 2008® series machines, the
organization introduced, today, the Crit-Line® IV monitor, a
stand-alone device providing access to patient profile information,
including hematocrit, oxygen and percent change in intravascular
blood volume during treatment.
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier healthcare
company focused on providing the highest quality care to people
with renal and other chronic conditions. Through its
industry-leading network of dialysis facilities, outpatient cardiac
and vascular labs, and urgent care centers, as well as the
country’s largest practice of hospitalist and post-acute providers,
Fresenius Medical Care provides coordinated healthcare services at
pivotal care points for hundreds of thousands of chronically ill
customers throughout the continent. As the world’s largest fully
integrated renal company, it offers specialty pharmacy and
laboratory services, and manufactures and distributes the most
comprehensive line of dialysis equipment, disposable products, and
renal pharmaceuticals. For more information, visit the FMCNA
website at www.freseniusmedicalcare.us. For information about
Crit-Line Technology visit www.fmcna-crit-line.com.
Indications for Use: The Crit-Line IV monitor is used to
non-invasively measure hematocrit, oxygen saturation and percent
change in blood volume. The sensor clip measures hematocrit,
percent change in blood volume and oxygen saturation in real time
for application in the treatment of dialysis patients with the
intended purpose of providing a more effective treatment for both
the dialysis patient and the clinician. Based on the data that the
monitor provides, the clinician/nurse, under physician direction,
intervenes (i.e. increases or decreases the rate at which fluid is
removed from the blood) in order to remove the maximum amount of
fluid from the dialysis patient without the patient experiencing
the common complications of dialysis which include nausea, cramping
and vomiting. The Crit-Line blood chamber is a sterile, single use,
disposable, optical cuvette designed for use with the Crit-Line
sensor clip during acute and chronic hemodialysis therapy to
non-invasively measure hematocrit, percent change in blood volume
and oxygen saturation. The blood chamber is connected between the
arterial bloodline and the dialyzer within the extracorporeal
circuit during the hemodialysis treatment.
The CLiC device is used with the 2008T hemodialysis machine to
non-invasively measure hematocrit, oxygen saturation and percent
change in blood volume. The CLiC device measures hematocrit,
percent change in blood volume and oxygen saturation in real time
for application in the treatment of dialysis patients with the
intended purpose of providing a more effective treatment for both
the dialysis patient and the clinician. Based on the data that the
monitor provides, the clinician/nurse, under physician direction,
intervenes (i.e., increases or decreases the rate at which fluid is
removed from the blood) in order to remove the maximum amount of
fluid from the dialysis patient without the patient experiencing
the common complications of dialysis which include nausea, cramping
and vomiting. The CLiC blood chamber is a sterile, single use,
disposable, optical cuvette designed for use with the CLiC
monitor's sensor clip during acute and chronic hemodialysis therapy
to non-invasively measure hematocrit, percent change in blood
volume and oxygen saturation. The blood chamber is connected
between the arterial bloodline and the dialyzer within the
extracorporeal circuit during the hemodialysis treatment. The 2008T
hemodialysis machine is indicated for acute and chronic dialysis
therapy.
Caution: Federal (US) law restricts these devices to sale
by or on the order of a physician.
Note: Read the Instructions for Use for safe and proper
use of these devices. For a complete description of hazards,
contraindications, side effects and precautions, see full package
labeling at www.fmcna.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160502005698/en/
Media Contact:Fresenius Medical Care North AmericaJon
StoneJonathan.d.stone@fmc-na.comOffice: 781-699-9704Cell:
781-392-4680
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024